SMN1 and proximal spinal muscular atrophy: It can be inferred from the preclinical studies using mouse models that restoration of SMN in both the periphery and the CNS could rescue patients with SMA more dramatically than the current treatment method of intracerebroventricular (ICV) injection, which can deliver drugs into the CNS.